A pilot study of the efficacy and tolerability of bupropion extended release (Wellbutrin XL) for the treatment of major depressive disorder in women with breast cancer

Trial Profile

A pilot study of the efficacy and tolerability of bupropion extended release (Wellbutrin XL) for the treatment of major depressive disorder in women with breast cancer

Completed
Phase of Trial: Phase II/III

Latest Information Update: 24 Jul 2007

At a glance

  • Drugs Bupropion (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2007 The expected completion date for this trial is now 1 Jan 2007.
    • 16 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top